Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Bls 1 frá 100 niðurstöður
Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The invention relates to pharmaceutical preparations useful for treating contact dermatitis having both an anti-histamine and an anti-inflammatory and methods of using said compounds. In one embodiment, the preparation is a composition of diphenhydramine and triamcinolone for
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention relates to improved dosage forms of pharmaceuticals for treating rhinitis associated with allergies and colds.
BACKGROUND OF THE INVENTION
Decongestants and Antihistamines
Rhinitis refers to an inflammatory disorder of the nasal passages. The symptoms of
Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Aug. 18, 2014, is named LIAI0433629_ST25.txt and is 21,069 bytes in
Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a method for treating inflammatory bowel disease by administering histamine H.sub.3 receptor agonists.
2. Summary of the Related Art
Histamine (2-(4-imidazolyl)ethylamine) is found naturally in most tissues of both
Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for topical application, intended, in particular, for the treatment of sensitive skins, as well as to a composition
Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for topical application, intended, in particular, for the treatment of sensitive skins, as well as to a
Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF .alpha.antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for topical application, intended, in particular, for the treatment of sensitive skins, as well as to a
1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 receptor agents
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD
This invention relates to compounds having pharmacological activity, to compositions containing these compounds, and to a medical method of treatment employing the compounds and compositions. More particularly, this invention concerns 1H-4(5)-substituted imidazole derivatives and
Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT
The sequence listing written in the file 483620_SEQLST.txt is 18,070 bytes, and was created on Aug. 23, 2016 and is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or
Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT
The sequence listing written in the file 413219_SEQLST.TXT is 18,027 bytes, and was created on Jun. 11, 2012 and is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or
Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or pass through cells and/or be taken up by cellular organelles to reach their intended therapeutic target. Many larger molecules and some small ones by themselves have limited capacity to pass through cellular membranes.
Proteoglycan compositions for treating prostate and bladder inflammatory conditions
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglyean that are designed to be used as dietary
Proteoglycan compositions for treatment of cardiovascular inflammatory diseases
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
Proteoglycan compositions for treating arthritic inflammatory conditions
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
Proteoglycan compositions for treating arthritic inflammatory conditions
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum
- Virkar á 55 tungumálum
- Jurtalækningar studdir af vísindum
- Jurtaviðurkenning eftir ímynd
- Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
- Lestu vísindarit sem tengjast leit þinni
- Leitaðu að lækningajurtum eftir áhrifum þeirra
- Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum
Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum
